Cardiac resynchronisation therapy in patients with left bundle branch block with residual conduction.

Cardiac resynchronisation therapy Heart failure Left bundle branch block Left bundle branch block with residual conduction

Journal

Indian pacing and electrophysiology journal
ISSN: 0972-6292
Titre abrégé: Indian Pacing Electrophysiol J
Pays: Netherlands
ID NLM: 101157207

Informations de publication

Date de publication:
Historique:
received: 03 06 2020
revised: 29 10 2020
accepted: 31 10 2020
pubmed: 20 11 2020
medline: 20 11 2020
entrez: 19 11 2020
Statut: ppublish

Résumé

To evaluate whether left bundle branch block with residual conduction (rLBBB) is associated with worse outcomes after cardiac resynchronisation therapy (CRT). All consecutive CRT implants at our institution between 2006 and 2013 were identified from our local device registry. Pre- and post-implant patient specific data were extracted from clinical records. A total of 690 CRT implants were identified during the study period. Prior to CRT, 52.2% of patients had true left bundle branch block (LBBB), 19.1% a pacing-induced LBBB (pLBBB), 11.2% a rLBBB, 0.8% a right bundle branch block (RBBB), and 16.5% had a nonspecific intraventricular conduction delay (IVCD) electrocardiogram pattern. Mean age at implant was 67.5 years (standard deviation [SD] = 10.6), mean left ventricular ejection fraction (LV EF) was 25.7% (SD = 7.9%), and mean QRS duration was 158.4 ms (SD = 32 ms). After CRT, QRS duration was significantly reduced in the LBBB (p < 0.001), pLBBB (p < 0.001), rLBBB (p < 0.001), RBBB (p = 0.04), and IVCD groups (p = 0.03). LV EF significantly improved in the LBBB (p < 0.001), rLBBB (p = 0.002), and pLBBB (p < 0.001) groups, but the RBBB and IVCD groups showed no improvement. There was no significant difference in mortality between the LBBB and rLBBB groups. LV EF post-CRT, chronic kidney disease, hyperkalaemia, hypernatremia, and age at implant were significant predictors of mortality. CRT in patients with rLBBB results in improved LV EF and similar mortality rates to CRT patients with complete LBBB. Predictors of mortality post-CRT include post-CRT LV EF, presence of CKD, hyperkalaemia, hypernatremia, and older age at implant.

Identifiants

pubmed: 33212244
pii: S0972-6292(20)30133-9
doi: 10.1016/j.ipej.2020.10.006
pmc: PMC7854372
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

14-17

Informations de copyright

Copyright © 2020 Indian Heart Rhythm Society. Production and hosting by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None.

Références

Circulation. 2008 May 20;117(20):2608-16
pubmed: 18458170
J Cardiovasc Electrophysiol. 2010 Jul;21(7):781-5
pubmed: 20132380
Circulation. 2011 Mar 15;123(10):1061-72
pubmed: 21357819
Europace. 2013 Aug;15(8):1070-118
pubmed: 23801827
Eur Heart J. 2006 Jun;27(12):1423-30
pubmed: 16682380
Am Heart J. 2011 Mar;161(3):552-7
pubmed: 21392611
N Engl J Med. 2010 Dec 16;363(25):2385-95
pubmed: 21073365
N Engl J Med. 2009 Oct 1;361(14):1329-38
pubmed: 19723701
Pacing Clin Electrophysiol. 2009 Mar;32 Suppl 1:S236-9
pubmed: 19250104
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
J Am Coll Cardiol. 2003 Dec 17;42(12):2109-16
pubmed: 14680736
Pacing Clin Electrophysiol. 2009 Mar;32 Suppl 1:S120-5
pubmed: 19250074
Circulation. 1974 Sep;50(3):479-86
pubmed: 4416092
J Am Coll Cardiol. 2004 Nov 2;44(9):1834-40
pubmed: 15519016
J Am Coll Cardiol. 2012 Jun 19;59(25):2366-73
pubmed: 22698490
J Am Coll Cardiol. 2005 Dec 20;46(12):2183-92
pubmed: 16360044
Eur Heart J. 2007 Jan;28(1):33-41
pubmed: 17121757
Curr Opin Cardiol. 2006 Jan;21(1):20-6
pubmed: 16355025
Europace. 2012 May;14(5):690-5
pubmed: 22170897

Auteurs

Christian Grebmer (C)

Deutsches Herzzentrum München, Klinik für Herz- uns Kreislauferkrankungen, Klinik an der Technischen Universität München, München, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany. Electronic address: Grebmer_C@gmx.at.

Lena Friedrich (L)

Deutsches Herzzentrum München, Klinik für Herz- uns Kreislauferkrankungen, Klinik an der Technischen Universität München, München, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.

Verena Semmler (V)

Deutsches Herzzentrum München, Klinik für Herz- uns Kreislauferkrankungen, Klinik an der Technischen Universität München, München, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.

Marc Kottmaier (M)

Deutsches Herzzentrum München, Klinik für Herz- uns Kreislauferkrankungen, Klinik an der Technischen Universität München, München, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.

Felix Bourier (F)

Deutsches Herzzentrum München, Klinik für Herz- uns Kreislauferkrankungen, Klinik an der Technischen Universität München, München, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.

Amir Brkic (A)

Deutsches Herzzentrum München, Klinik für Herz- uns Kreislauferkrankungen, Klinik an der Technischen Universität München, München, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.

Patrick Blazek (P)

Deutsches Herzzentrum München, Klinik für Herz- uns Kreislauferkrankungen, Klinik an der Technischen Universität München, München, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.

Severin Weigand (S)

Deutsches Herzzentrum München, Klinik für Herz- uns Kreislauferkrankungen, Klinik an der Technischen Universität München, München, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.

Matthew O' Connor (MO)

Wellington Hospital, Department of Cardiology, Wellington, New Zealand.

Isabel Deisenhofer (I)

Deutsches Herzzentrum München, Klinik für Herz- uns Kreislauferkrankungen, Klinik an der Technischen Universität München, München, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.

Gabriele Hessling (G)

Deutsches Herzzentrum München, Klinik für Herz- uns Kreislauferkrankungen, Klinik an der Technischen Universität München, München, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.

Christof Kolb (C)

Deutsches Herzzentrum München, Klinik für Herz- uns Kreislauferkrankungen, Klinik an der Technischen Universität München, München, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.

Carsten Lennerz (C)

Deutsches Herzzentrum München, Klinik für Herz- uns Kreislauferkrankungen, Klinik an der Technischen Universität München, München, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.

Classifications MeSH